AMH-PHAMH-PHNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.84% | +8.43% | +8.03% | +7.51% | +5.19% |
| Gross Profit Growth | +9.01% | +9.28% | +10.18% | +10.50% | -91.68% |
| EBITDA Growth | +8.70% | +11.19% | +37.30% | +33.60% | +37.35% |
| Operating Income Growth | +8.70% | +11.19% | -46.32% | -46.72% | -49.51% |
| Net Income Growth | +58.19% | +0.61% | +14.02% | +33.06% | +0.46% |
| EPS Growth | +57.14% | +0.00% | +12.00% | +35.00% | +0.00% |
| EPS Diluted Growth | +57.14% | +0.00% | +12.00% | +35.00% | +0.00% |
| Weighted Average Shares Growth | +1.77% | +1.05% | +1.07% | +1.02% | +0.13% |
| Weighted Average Shares Diluted Growth | +1.79% | +1.03% | +1.02% | +0.95% | +0.07% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -11.38% | +10.72% | -0.78% | -4.42% | +42.69% |
| Free Cash Flow Growth | -29.57% | +8.14% | -2.69% | -17.65% | +328.47% |
| Receivables Growth | +11.60% | +15.00% | +14.96% | +12.66% | -12.35% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +5.46% | +4.14% | +2.17% | +3.19% | -1.04% |
| Book Value per Share Growth | +0.98% | +0.88% | +0.92% | +1.11% | -1.89% |
| Debt Growth | +12.21% | +9.34% | +3.30% | +7.19% | +1.96% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +12.33% | -8.44% | -11.05% | +1.77% | +5.35% |